CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Cash Flow Y/Y Annual
Purple Biotech Ltd   (PPBT)
Other Ticker:  
 
 

PPBT's Net Cash Flow Growth by Quarter and Year

Purple Biotech Ltd 's Net Cash Flow results by quarter and year




PPBT Net Cash Flow (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December 10.89 11.25 4.39 5.16
III Quarter September 0.00 0.00 0.00 -5.16
II Quarter June 0.00 0.00 0.00 5.16
I Quarter March 0.00 0.00 0.00 0.00
FY   10.89 11.25 4.39 5.16



PPBT Net Cash Flow fourth quarter 2022 Y/Y Growth Comment
Purple Biotech Ltd reported decrease in Net Cash Flow in the fourth quarter 2022 by -3.2% to $ 10.89 millions, from the same quarter in 2021.
The decrease in the fourth quarter 2022 Purple Biotech Ltd 's Net Cash Flow compares unfavorably to the Company's average Net Cash Flow jump of 42.26%.

Looking into fourth quarter 2022 results within Major Pharmaceutical Preparations industry 28 other companies have achieved higher Net Cash Flow growth. While Purple Biotech Ltd ' s Net Cash Flow decline of -3.2% ranks overall at the positon no. 263 in the fourth quarter 2022.


PPBT Net Cash Flow ( Y/Y Growth %) 2022
 2021 2020 2019
IV Quarter December -3.2 % 156.26 % -14.92 % 30.63 %
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   -3.2 % 156.26 % -14.92 % 30.63 %

Financial Statements
Purple Biotech Ltd 's fourth quarter 2022 Net Cash Flow $ 10.89 millions PPBT's Income Statement
Purple Biotech Ltd 's fourth quarter 2021 Net Cash Flow $ 11.25 millions Quarterly PPBT's Income Statement
New: More PPBT's historic Net Cash Flow Growth >>


PPBT Net Cash Flow (Quarter on Quarter Growth %)

 2022
 2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   -3.2 % 156.26 % -14.92 % 30.63 %


Go to PPBT Cash flow Statement >> Back to PPBT Growth rate Comparisons >>


Net Cash Flow fourth quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #29
Healthcare Sector #61
Overall #263

Net Cash Flow Y/Y Growth Statistics
High Average Low
156.49 % 42.26 % -15.07 %
(Dec 31 2021)   (Dec 31 2020)
Net Cash Flow fourth quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #29
Healthcare Sector #61
Overall #263
Net Cash Flow Y/Y Growth Statistics
High Average Low
156.49 % 42.26 % -15.07 %
(Dec 31 2021)   (Dec 31 2020)

Net Cash Flow by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Purple Biotech Ltd 's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PPBT's IV. Quarter Q/Q Net Cash Flow Comment


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PPBT's IV. Quarter Q/Q Net Cash Flow Comment


Purple Biotech Ltd 's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Dec 31 2022)		 12 Months Ending
0		 12 Months Ending
0		 12 Months Ending
0		 12 Months Ending
(Dec 31 2021)
Cumulative Net Cash Flow 12 Months Ending $ 10.89 $ 0.00 $ 0.00 $ 0.00 $ 11.25
Y / Y Net Cash Flow Growth (TTM) -3.17 % - - - 156.49 %
Year on Year Net Cash Flow Growth Overall Ranking # 404 # 404 # 404 # 404 # 526
Seqeuential Net Cash Flow Change (TTM) - - - - -
Seq. Net Cash Flow Growth (TTM) Overall Ranking # 404 # # # # 526

New: More PPBT's historic Net Cash Flow Growth >>



Cumulative Net Cash Flow growth Comment
Purple Biotech Ltd showed decline, but improvement compare to trailing twelve month Net Cash Flow decrease in 0. If the fiscal year would end in Dec 31 2022, Purple Biotech Ltd 's annual Net Cash Flow surge would be -3.17% year on year to $11 millions.

In the Healthcare sector 46 other companies have achieved higher trailing twelve month Net Cash Flow growth. While Net Cash Flow growth total ranking has deteriorated compare to previous quarter from to 404.

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 24
Healthcare Sector # 47
Overall # 219

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
156.49 %
42.26 %
-15.07 %
(Dec 31 2021)  


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Cash Flow growth Comment
Purple Biotech Ltd showed decline, but improvement compare to trailing twelve month Net Cash Flow decrease in 0. If the fiscal year would end in Dec 31 2022, Purple Biotech Ltd 's annual Net Cash Flow fall would be -3.17% year on year to $11 millions.

In the Healthcare sector 46 other companies have achieved higher trailing twelve month Net Cash Flow growth. While Net Cash Flow growth total ranking has deteriorated compare to previous quarter from to 404.

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 24
Healthcare Sector # 47
Overall # 219

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
156.49 %
42.26 %
-15.07 %
(Dec 31 2021)  


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Cash Flow Growth
Major Pharmaceutical Preparations Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
PPBT's Net Cash Flow Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for PPBT's Competitors
Net Cash Flow Growth for Purple Biotech Ltd 's Suppliers
Net Cash Flow Growth for PPBT's Customers

You may also want to know
PPBT's Annual Growth Rates PPBT's Profitability Ratios PPBT's Asset Turnover Ratio PPBT's Dividend Growth
PPBT's Roe PPBT's Valuation Ratios PPBT's Financial Strength Ratios PPBT's Dividend Payout Ratio
PPBT's Roa PPBT's Inventory Turnover Ratio PPBT's Growth Rates PPBT's Dividend Comparisons



Companies with similar Net Cash Flow fall for the quarter ending Dec 31 2022 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Dec 31 2022
Brainsway Ltd -0.24%$ -0.236 millions
Astrazeneca Plc-2.58%$ -2.575 millions
Nuvasive Inc-3.04%$ -3.040 millions
Purple Biotech Ltd -3.17%$ -3.174 millions
Mannkind Corporation-3.54%$ -3.545 millions
Calliditas Therapeutics Ab-4.09%$ -4.095 millions
Pharming Group N v -6.45%$ -6.451 millions
China Health Industries Holdings Inc -6.68%$ -6.684 millions
Galectin Therapeutics Inc -9.42%$ -9.416 millions
Cabaletta Bio Inc -10.05%$ -10.045 millions
Silk Road Medical Inc -11.70%$ -11.702 millions
Gsk Plc-12.89%$ -12.892 millions
Valneva Se-16.52%$ -16.515 millions
Inventiva S a -18.10%$ -18.104 millions
Xtl Biopharmaceuticals Ltd -18.23%$ -18.232 millions
Rasna Therapeutics Inc -19.83%$ -19.832 millions
Marpai Inc -20.85%$ -20.848 millions
Biolinerx Ltd -22.82%$ -22.821 millions
Ascendis Pharma A-23.65%$ -23.652 millions
Innate Pharma Sa-24.15%$ -24.151 millions
Apeiron Capital Investment Corp -26.15%$ -26.147 millions
Gilead Sciences Inc -26.95%$ -26.947 millions
4d Molecular Therapeutics Inc -27.91%$ -27.912 millions
American Shared Hospital Services-27.95%$ -27.945 millions
Koninklijke Philips Nv-28.61%$ -28.611 millions
Edap Tms Sa-29.06%$ -29.064 millions
Nanobiotix S a -29.57%$ -29.568 millions
Protagenic Therapeutics Inc new-29.84%$ -29.844 millions
Nucana Plc-31.01%$ -31.013 millions
Nls Pharmaceutics Ltd -34.10%$ -34.104 millions


Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com